PLYMOUTH MEETING, Pa., Nov. 12 /Xinhua-PRNewswire/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company"), today announced that due to the technical difficulties encountered on today's conference call, the company will hold a second call tomorrow, Wednesday, November 12, 2008. On this call, BMP Sunstone will give callers the opportunity to ask questions since technical difficulties prevented the Company from addressing all questions on today's call. The transcript of today's call will be posted on the company's website as soon as possible.
Details for Wednesday's Call
The Company will hold a conference call at 9:00 am ET on Wednesday, November 12, 2008. Listeners may access the call by dialing 1-888-713-4214 or 1-617.213.4866 for international callers, access code 93845949. A webcast will also be available through the Company's website at http://www.bmpsunstone.com . A replay of the call will be available through November 19, 2008. Listeners may access the replay by dialing 1-888-286-8010 or 1 617-801-6888 for international callers, access code: 41091128.
About BMP Sunstone Corporation
BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Currently this portfolio includes eight products under exclusive multi-year licenses for China, primarily focused on women's health and pediatrics. The Company also owns Sunstone Pharmaceutical Co. Ltd., which manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold through approximately 50,000 pharmacies in China. The Company also provides pharmaceutical distribution services through its subsidiaries in Beijing and Shanghai, and through its affiliate, Guangzhou Pharmaceuticals Corp. The Company has its main office in Beijing, with a US office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .
Safe Harbor Statement
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts, including but not limited to statements about the timing of the completion and terms of the proposed acquisition of 75% of Shengda, the Company's revenue and net income guidance for 2008, the timing of the launch of GoodBaby Multivitamin Granules or any other Company products, use of proceeds from the registered direct offering, the possibility of completing any future acquisitions or receiving profits from Alliance BMP Limited, the ability to successfully integrate the Company's distribution platform, the ability to realize synergies among existing and new Rx and OTC products and channels, future investment in the Company's product portfolio and national leading brands, the focus of the Company on revenue growth and market penetration of the Company's current products, expansion of the Company's product portfolio at BMP China, and solidification of Sunstone's market leader position. These statements are subject to uncertainties and risks including, but not limited to, negotiating definitive terms and definitive agreements regarding the proposed acquisition, satisfying the conditions in such definitive agreements, regulatory review, sales and marketing, operating performance, general financial, economic, and political conditions affecting the biotechnology and pharmaceutical industries and the Chinese pharmaceutical market, the ability to timely manufacture and distribute the Company's products, the need to use cash for unexpected reasons, the results of Alliance BMP Limited operations are less than expected or Alliance BMP Limited decides not to make a distribution of profits to its equityholders, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
